ModiQuest attends PEGS 2013 in Boston (April 29 to May 3, 2013).  At the event, ModiQuest presents posters on its novel Anti-Citrullinated Protein Antibodies for Rheumatoid Arthritis and its novel human anti-MMP14 antibodies for Oncology.  ModiQuest has made these discoveries using its proprietary antibody discovery technology platforms ModiFuse™ (highly efficient hybridoma electrofusion technology), ModiSelect™ (B-cell … Continue reading